The lung in distress

Advances in Experimental Medicine and Biology

Volumn 388, Issue , 1996, Pages 463-471

  So, K L ^a   Lachmann, B ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; LUNG ALVEOLUS SURFACE TENSION; LUNG CAPILLARY; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG VENTILATION PERFUSION RATIO; PRIORITY JOURNAL; TISSUE OXYGENATION;

EID: 0029796622     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0333-6_59     Document Type: Conference Paper

References (46)

1. Spragg, R.G., and Smith, R.M., 1991, Biology of acute lung injury In: Crystal, R.G., and West, J.B., (eds): The Lung: scientific foundations, Raven Press, Ltd., New York, 2003-2017.
2. Rinaldo, J. E., and Christman, J. W., 1990, Mechanisms and mediators of the adult respiratory distress syndrome, Clin.Chest.Med. 11:621-632.
3. Beer, D. J., 1992, ARDS: evolving concepts of a systemic disease, Hosp. Pract. 27(a):57-80.
4. Macnaughton, P. D., and Evans, T. W., 1992, Management of adult respiratory distress syndrome, N.Engl.J.Med. 469-472.
5. Ashbaugh, D. G., Bigelow, D. B., Petty, T. L., and Levine, B. E., 1967, Acute respiratory distress in adults, Lancet 2:319-323.
6. Petty, T. L., and Ashbaugh, D. G., 1971, The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management, Chest 60:233-239.
7. Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., LeGall, J. R., Morris, A., Spragg, R., and the Consensus Committee, 1994, The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination, Am.J.Respir.Crit.Care.Med. 149:818-824.
8. Petty, T. L., Reiss, O. K., Paul, G. W., and Elkins, N. D., 1977, Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock, Am.Rev.Resp.Dis. 115:531-536.
9. Petty, T. L., Silvers, W., Paul, G. W., and Stanford, R. E., 1979, Abnormailities in lung elastic properties and surfactant function in adult respiratory distress syndrome, Chest 75:571-574.
10. Lachmann, B., Bergmann, K.-C., Enders, K., Friebel, L., Gehlmannn, B., Grossman, G., Hoffmann, D., Kuckelt, W., Malmquist, H., Robertson, B., Seidel, M., Vogel, J., and Winsel, K., 1977, Konnen pathologische veranderungen im surfactant-system der lunge zu einer akuten rtespiratorischen insuffizienz beim erwachsenen fuhren? In: Danzmann, E. (ed): Anaesthesia 77, Proceedings of the 6th congress of the society of Anaesthesiology and Resuscitation of the G.D.R., Berlin, 337-353.
11. Hallman, M., Spragg, R., Harrell, J. H., Moser, K., M., and Gluck, L., 1982, Evidence of lung surfactant abnromality in respiratory failure. J.Clin.Invest. 70:673-683.
12. Pison, U., Seeger, W., Buchhorn, R., Joka, T., Brand, M., Obertacke, U., Neuhof, H., and Schmit-Neurenburg, K. P., 1989, Surfactant abnormalities in patients with respiratory failure after multiple trauma, Am.Rev.Resp.Dis. 140:1033-1039.
13. Gregory, T. J., Longmore, W. J., Moxley, W. J., Whitsett, J. A., Reed, C. R., Fowler III, A. A., Hudson, L. D., Maunder, R. J., Crim, C., and Hyers, T. M., 1991, Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J.Clin.Invest. 88: 1976-1981.
14. Lachmann, B. and Van Daal, G. J., 1992, Adult respiratory distress syndrome: animal models, In: Robertson, B., Van Golde, L. M. G., Batenburg, J. J. (eds): Pulmonary surfactant. Amsterdam, Elsevier, 635-663.
15. Tierney, D. F., and Johnson, R. P., 1965, Altered surface tension of lung extracts and lung mechanics, J.Appl.Physiol. 20:1253-1260.
16. Seeger, W., Stohr, G., Wolf, H. R. D., and Neuhof, H., 1985, Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J.Appl.Physiol. 58:326-338.
17. Fuchiraukai, T., Fujiwara, T., Takahashi, A., and Enhorning, G., 1987, Artificial pulmonary surfactant inhibited by proteins, J.Appl.Physiol. 62:429-437.
18. Lachmann, B., 1987, The role of pulmonary surfactant in the pathogcnesis and therapy of ARDS. In: Vincent, J.L.(ed), Update in intensive care and emergency medicine. Berlin Heidelberg New York, Springer-Verlag, 123-134.
19. Richman, P. S., Spragg, R. G., Robertson, B., Merritt, T. A., and Curstedt, T., 1989, The adult respiratory distress syndrome: first trials with surfactant replacement, Eur.Respir.J. 2:109s-111s.
20. Joka, Th., and Obertacke, U., 1989, Neue medikamentöse Behandlung im ARDS: Effekt einer intrabronchialen xenogenen Surfactantapplikation. Z.Herz-.Thorax-,Gefäßchir., 3:21-24.
21. Nosaka, S., Sakai, T., Yonekura, M., and Yoshikawa, K., 1990, Surfactant for adults with respiratory failure, Lancet 1:947-948.
22. Marraro, G., Casiragi, G., and Riva, A., 1991, Effets d'un apport de surfactant chez deux adolescents leucémiques atteints de détresse respiratoire, Cahiers d'Anesthesiologie 39:227-232.
23. ®) in human sepsis-induced ARDS, Chest 100:137S.
24. ®), Am.Rev.Respir.Dis. 145:A184.
25. Stubbig, K., Schmidt, H., Bohrer, H., Hulster, Th., Bach, A., Motsch, J., 1992, Surfactantapplikation bei akutem Lungenversagen, Anaesthesist 41:555-558.
26. Spragg, R. G., Gilliard, N., Richman, P., Smith, R. M., Hite, R. D., Pappert, D., Robertson, B., Curstedt, T., and Strayer, D., 1994, Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome, Chest 105:195-202.
27. Reines, H.D., Silverman, H., and Hurst, J., 1992, Effects of two concentrations of nebulized surfactant (Exosurf) in sepsis-induced ARDS, Int Care Med 20:S61.
28. Gommers, D., and Lachmann, B., 1993, Does surfactant play a role in adults?. Clinical Intensive Care 4: 284-295.
29. Heikinheimo, M., Hynynen, M., Rautiainen, P., Andersson, S., Hallman, M., and Kukkonen, S., 1994, Successful treatment of ARDS with two doses of synthetic surfactant, Chest 105(4): 1263-1264.
30. Gregory, T. J., Longmore, W. J., Moxley, M. A., Cai, G-Z., Gadek, J. E., Weiland, J. E., Hyers, T. M., Crim, C., Hudson, L. D., Steinberg, K. P., Maunder, R. A., Spragg, R. G., Smith, R. M., Tierney, D. F., and Gipe, B., 1994, Surfactant repletion following Survanta supplementation in patients with acute respiratory failure (ARDS), Am.J.Respir.Crit.Care.Med. 149:A124.
31. Von Neergaard, K., 1929, Neue auffassungen uber einen grundbegriff der atemmechanik. Die retraktionskraft der Lunge, abhangig von der oberflachenspannung in den alveolen. Z.Ges.Exp.Med. 66:373-394.
32. Clark, L. C., and Golan, F., 1966, Survival of mammals breathing organic liquids equilibrated with oxygen at atmosphere pressure, Science 152:1755-1756.
33. Greenspan, J. S., Wolfson, M. R., Rubenstein, S. D., and Shaffer, T. H., 1990, Liquid ventilation of human preterm neonates, J.Pediatr. 117:106-111.
34. Fuhrman, B. P., Paczan, P. R., and DeFrancis, M., 1991, Perfluocarbon-associated gas exchange, Crit.Care.Med. 19:712-722.
35. Lewis, J. F. and Jobe, A. H., 1993, Surfactant and the adult respiratory distress syndrome, Am.Rev.Resp.Dis. 147:218-233.
36. Tütüncü, A. S., Faithfull, N. S., and Lachmann, B., 1993, Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: dose-dependent improvement of gas-exchange, Crit.Care.Med. 21:962-969
37. Tütüncü, A. S., Faithfull, N. S., and Lachmann, B., 1993, Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome, Anesthesiology 79:1083-1093.
38. Tütüncü, A. S., Faithfull, N. S., and Lachmann, B., 1993, Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure, Am.Rev.Resp.Dis. 148:785-792
39. Furchgott, R. F., and Zawadzki, J. V., 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature 288:373-376.
40. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G., 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc.Natl.Acad.Sci.USA. 84:9265-9269.
41. Palmer, R. M., Ferrige, A. G., Moncada, S., 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature 327:524-526.
42. Falke, K. J., Rossaint, R., Pison, U., Slama, K., Lopez, F., Santak, B., and Zapol, W.M., 1991, Inhaled nitric oxide selectively reduces pulmonary hypertension in severe ARDS and improves gas exchange as well as right heart ejection fraction: a case report, Am.Rev.Resp.Dis. 143:A248.
43. Rossaint, R., Falke, K. J., Lopez, F., Slama, K., Pison, U., and Zapol, W. M., 1993, Inhaled nitric oxide in adult respiratory distress syndrome, N.Engl.J.Med. 328:399-405.
44. Gerlach, H., Rossaint, R., Pappert, D., and Falke, K. F., 1993, Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome, Eur.J.Clin.Invest. 23:499-502.
45. Houmes, R. J., Verbrugge, S., Zimmerman, L., Gommers, D., Lachmann, B., 1994, The influence of nitric oxide on the pulmonary surfactant system, Int.Care.Med. 20:543
46. Gommers, D., Houmes, R. J. M., Olsson, S. G., So, K. L., Lachmann, B., 1994, Exogenous surfactant and nitric oxide have a synergetic effect in improving respiratory failure, Am.J.Respir.Crit.Care.Med. 149:A568.